Publications in collaboration with researchers from Fred Hutchinson Cancer Research Center (4)

2021

  1. Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

    Leukemia, Vol. 35, Núm. 5, pp. 1344-1355

2020

  1. Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis

    Blood Advances, Vol. 4, Núm. 22, pp. 5825-5835

2018

  1. Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

    Journal of Cancer Research and Clinical Oncology, Vol. 144, Núm. 5, pp. 945-954

2017

  1. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the ENESTfreedom study

    Leukemia, Vol. 31, Núm. 7, pp. 1525-1531